id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2017-D-4303-0005,FDA,FDA-2017-D-4303,Providing Regulatory Submissions in Electronic Format — Content of the Risk Evaluation and Mitigation Strategies Document Using Structured Product Labeling Guidance for Industry,Other,Guidance,2021-01-05T05:00:00Z,2021,1,2021-01-05T05:00:00Z,,2024-11-06T23:44:55Z,,1,0,09000064849df523
FDA-2017-D-4303-0003,FDA,FDA-2017-D-4303,Providing Regulatory Submissions in Electronic Format—Content of the Risk Evaluation and Mitigation Strategies Document Using Structured Product Labeling; Guidance for Industry; Availability,Notice,Notice of Availability,2020-12-28T05:00:00Z,2020,12,2020-12-28T05:00:00Z,,2020-12-28T16:56:08Z,2020-28560,0,0,09000064849cc7af
FDA-2017-D-4303-0002,FDA,FDA-2017-D-4303,Guidance for Industry REMS.eSub,Other,Guidance,2020-12-23T05:00:00Z,2020,12,2020-12-23T05:00:00Z,,2024-11-12T23:27:37Z,,1,0,09000064849c3775
FDA-2017-D-4303-0001,FDA,FDA-2017-D-4303,Providing Regulatory Submissions in Electronic Format—Content of the Risk Evaluation and Mitigation Strategies Document Using Structured Product Labeling; Draft Guidance for Industry; Availability; Correction,Notice,Correction,2019-07-05T04:00:00Z,2019,7,2019-07-05T04:00:00Z,,2019-07-25T23:41:42Z,2019-14362,0,0,0900006483d608ba